Found: 15
Select item for more details and to access through your institution.
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 6, p. 623, doi. 10.1007/s11912-023-01402-8
- By:
- Publication type:
- Article
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3595, doi. 10.3390/ijms19113595
- By:
- Publication type:
- Article
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1176-1
- By:
- Publication type:
- Article
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patients.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04184-6
- By:
- Publication type:
- Article
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-03971-5
- By:
- Publication type:
- Article
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920949418
- By:
- Publication type:
- Article
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920949418
- By:
- Publication type:
- Article
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03728-z
- By:
- Publication type:
- Article
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04419-6
- By:
- Publication type:
- Article
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04419-6
- By:
- Publication type:
- Article
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-03971-5
- By:
- Publication type:
- Article
Asymptomatic azygos vein overflow in a young patient with primary mediastinal seminoma.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 12, p. 2308, doi. 10.1111/1759-7714.13170
- By:
- Publication type:
- Article
Occurrence of asymptomatic atrial fibrillation in non-ambulatory patients: a retrospective study in primary care setting.
- Published in:
- Family Medicine & Primary Care Review, 2024, v. 26, n. 2, p. 228, doi. 10.5114/fmpcr.2024.139034
- By:
- Publication type:
- Article
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9345, doi. 10.3390/ijms25179345
- By:
- Publication type:
- Article